Herein, we used a genomic database to analyze the correlation between Znf179 expression and prognosis in glioma patients, and found that Znf179 messenger (m)RNA and protein expression levels were relatively lower in glioblastoma tissues compared to normal tissues. Here, RNF112 is linked to central nervous system cancer.